Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mounier

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patientsC Haioun, N Mounier, B Quesnel, et al.
Bone Marrow Transplantation|August 29, 2007
Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantationsE Foïs, M Desmartin, S Benhamida, et al.
Bone Marrow Transplantation|November 29, 2016
First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphomaD Ghez, C Fortpied, N Mounier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trialN Mounier, P Brice, S Bologna, et al.
Bone Marrow Transplantation|September 20, 2016
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.
Bone Marrow Transplantation|September 15, 2015
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.
Presse Medicale (Paris, France : 1983)|March 31, 2005
[Therapeutic intensification and autologous stem cell transplantation in autoimmune diseases]Z Marjanovic, I Gerber, C Toledano, et al.
Leukemia|November 15, 2014
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1αJ Chiche, S Pommier, M Beneteau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)A S Cottereau, S Becker, F Broussais, et al.
Blood|July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 studyR-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patientsC Haioun, N Mounier, B Quesnel, et al.
Bone Marrow Transplantation|August 29, 2007
Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantationsE Foïs, M Desmartin, S Benhamida, et al.
Bone Marrow Transplantation|November 29, 2016
First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphomaD Ghez, C Fortpied, N Mounier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trialN Mounier, P Brice, S Bologna, et al.
Bone Marrow Transplantation|September 20, 2016
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.
Bone Marrow Transplantation|September 15, 2015
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL studyE Van Den Neste, N Schmitz, N Mounier, et al.
Presse Medicale (Paris, France : 1983)|March 31, 2005
[Therapeutic intensification and autologous stem cell transplantation in autoimmune diseases]Z Marjanovic, I Gerber, C Toledano, et al.
Leukemia|November 15, 2014
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1αJ Chiche, S Pommier, M Beneteau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)A S Cottereau, S Becker, F Broussais, et al.
Blood|July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 studyR-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Pageof 7